Achieve Life Sciences, Inc. Payments to Acquire Marketable Securities
Achieve Life Sciences, Inc. (ACHV) reported Payments to Acquire Marketable Securities of $139.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-11
- Achieve Life Sciences, Inc. payments to acquire marketable securities for the quarter ending 2026-06-30 was $138.82M, a 15375.81% increase year-over-year.
- Achieve Life Sciences, Inc. payments to acquire marketable securities for the quarter ending 2026-03-31 was $1.16M, a 65.63% decline year-over-year.
- Achieve Life Sciences, Inc. payments to acquire marketable securities for the quarter ending 2025-09-30 was $15.40M, a 3859.90% increase year-over-year.
- Achieve Life Sciences, Inc. payments to acquire marketable securities for the quarter ending 2025-06-30 was $897.00K.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month |
|---|---|---|---|
| 2026-06-30 | $138.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $139.97M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $1.16M 10-Q · filed 2026-05-12 | ||
| 2025-09-30 | $15.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $16.30M derived: sum of 2 quarters · filed 2026-08-11 | $19.66M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $897.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $4.26M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $3.36M 10-Q · filed 2026-05-12 | ||
| 2024-09-30 | $389.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $46.96M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $46.57M 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |